Capital Investment Services of America Inc. Increases Stock Holdings in Danaher Corporation $DHR

Capital Investment Services of America Inc. increased its position in shares of Danaher Corporation (NYSE:DHR) by 0.9% in the 2nd quarter, Holdings Channel.com reports. The firm owned 134,533 shares of the conglomerate’s stock after acquiring an additional 1,242 shares during the quarter. Danaher makes up 2.4% of Capital Investment Services of America Inc.’s portfolio, making the stock its 18th biggest holding. Capital Investment Services of America Inc.’s holdings in Danaher were worth $26,576,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds have also made changes to their positions in the company. GHP Investment Advisors Inc. raised its position in Danaher by 396.0% in the first quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate’s stock valued at $25,000 after purchasing an additional 99 shares during the period. Sierra Ocean LLC grew its stake in shares of Danaher by 116.9% in the first quarter. Sierra Ocean LLC now owns 141 shares of the conglomerate’s stock valued at $29,000 after buying an additional 76 shares in the last quarter. Smallwood Wealth Investment Management LLC purchased a new stake in shares of Danaher in the 1st quarter valued at $31,000. Red Tortoise LLC lifted its stake in Danaher by 175.0% during the 2nd quarter. Red Tortoise LLC now owns 154 shares of the conglomerate’s stock worth $30,000 after acquiring an additional 98 shares in the last quarter. Finally, Costello Asset Management INC purchased a new position in Danaher during the 1st quarter valued at about $41,000. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Danaher Stock Performance

NYSE:DHR opened at $218.06 on Thursday. Danaher Corporation has a 12 month low of $171.00 and a 12 month high of $260.88. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.62 and a quick ratio of 1.22. The firm has a market capitalization of $156.14 billion, a PE ratio of 44.96, a price-to-earnings-growth ratio of 3.20 and a beta of 0.77. The business’s fifty day moving average price is $202.24 and its 200 day moving average price is $197.73.

Danaher (NYSE:DHR) last announced its quarterly earnings results on Tuesday, October 21st. The conglomerate reported $1.89 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.72 by $0.17. Danaher had a return on equity of 10.93% and a net margin of 14.44%.The company had revenue of $6.05 billion during the quarter, compared to the consensus estimate of $6 billion. During the same period in the previous year, the business earned $1.71 EPS. Danaher’s revenue for the quarter was up 4.4% on a year-over-year basis. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. On average, sell-side analysts anticipate that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Friday, September 26th will be issued a $0.32 dividend. The ex-dividend date is Friday, September 26th. This represents a $1.28 annualized dividend and a dividend yield of 0.6%. Danaher’s dividend payout ratio is presently 27.23%.

Insider Activity

In related news, Director Teri List sold 2,778 shares of the stock in a transaction on Friday, August 22nd. The shares were sold at an average price of $211.06, for a total value of $586,324.68. Following the transaction, the director directly owned 20,751 shares of the company’s stock, valued at $4,379,706.06. This trade represents a 11.81% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Insiders own 11.10% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages have issued reports on DHR. Cowen reiterated a “buy” rating on shares of Danaher in a research note on Wednesday. JPMorgan Chase & Co. upped their target price on shares of Danaher from $260.00 to $270.00 and gave the stock an “overweight” rating in a research note on Wednesday. Wells Fargo & Company raised their price target on shares of Danaher from $205.00 to $230.00 and gave the company an “equal weight” rating in a research report on Wednesday. Weiss Ratings restated a “hold (c-)” rating on shares of Danaher in a research note on Wednesday, October 8th. Finally, Bank of America decreased their target price on Danaher from $230.00 to $220.00 and set a “buy” rating for the company in a report on Monday, September 22nd. Seventeen equities research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $243.39.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.